Navigation Links
Faust Pharmaceuticals' Phase IIa Results for Parkinson's Disease,Presented at International Congress of Parkinson's Disease and,Movement Disorders

tely, we hope to demonstrate that FP0011 can be a potent, safe glutamate release inhibitor that could have a role in other neurological diseases and conditions where excess glutamate has been implicated, such as Alzheimer's disease, ALS, Huntington's disease, multiple sclerosis and neuropathy."

About Parkinson's disease Parkinson's disease affects both men and women in almost equal numbers with no apparent social, ethnic, economic or geographic links. In the United States, it is estimated that 60,000 new cases are diagnosed each year, joining the 1.5 million Americans who currently have Parkinson's disease. While the condition usually develops after the age of 65, 15% of those diagnosed are under 50. Estimates range up to about 1,200,000 patients in Europe.

About Faust Pharmaceuticals - www.faustpharma.com Faust Pharmaceuticals is a clinical stage products company specializing in the discovery and development of drugs for diseases of the nervous system. The company's lead compound, FP0011, is a small molecule glutamate inhibitor in Phase II for Parkinson's disease and ALS. A second compound, FP0023, is a fetal gene activating utrophin inducer in preparation for Phase I/II for Duchenne Muscular Dystrophy. The company additionally has pre-clinical programs on targets such as mGluR (metabotropic glutamate receptor), as well as a proprietary drug discovery platform targeting GPCRs (G-Protein Coupled Receptors).

For further information, please contact:
Andrew Lloyd & Associates Andrew Lloyd / Neil Hunter Tel: +44 1273 675100 allo@ala.com>allo@ala.com / neil@ala.com>neil@ala.com

Katie Ollerenshaw ANDREW LLOYD & ASSOCIATES http://www.ala.com




Page: 1 2 3 4

Related medicine technology :

1. Data from Rexahn Pharmaceuticals Phase I Trial of RX-0201 (Archexin) to Be Presented at the 43rd American Society of Clinical Oncology Annual Meeting in Chicago
2. VGX Pharmaceuticals Novel HIV and Pandemic Influenza DNA Vaccine Candidates Trigger Robust Immune Responses and Protection in Pre-Clinical Models
3. Aeolus Pharmaceuticals AEOL 10113 May Play an Important Role Regulating the Oxidative Damage Induced by Ionizing Radiation
4. Aeolus Pharmaceuticals AEOL 10113 Demonstrates Potential as a Protector of Healthy Normal Cells from Cancer Radiation Therapy
5. Aeolus Pharmaceuticals AEOL 10150 Highlighted in Nature Genetics Publication
6. ACADIA Pharmaceuticals Schizophrenia Programs to Be Presented at the 2007 International Congress on Schizophrenia Research
7. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
8. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
9. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
10. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
11. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
Post Your Comments:
(Date:3/6/2015)... 6, 2015  Isis Pharmaceuticals, Inc. (NASDAQ: ... $9 million milestone payment from Biogen Idec related to ... Rx in infants with spinal muscular atrophy (SMA).  ... ISIS-SMN Rx, is a randomized, double-blind, sham-procedure controlled ... SMA.  The study will evaluate the efficacy and safety ...
(Date:3/5/2015)... --  MeridianRx earned highest possible score of ... indicators during its recent URAC accreditation review for ... proud of earning this level of accreditation from ... Officer of MeridianRx. "It is a testament to ... and innovation." URAC,s leading indicators are ...
(Date:3/5/2015)... DIEGO , March 5, 2015  Pfenex ... engaged in the development of biosimilar therapeutics including ... today that its fourth quarter and full year ... March 16, 2015, before the market opens for ... will host a conference call to discuss the ...
Breaking Medicine Technology:Isis Pharmaceuticals Earns $9M for Advancing ISIS-SMN Rx in Infants With Spinal Muscular Atrophy 2Isis Pharmaceuticals Earns $9M for Advancing ISIS-SMN Rx in Infants With Spinal Muscular Atrophy 3Isis Pharmaceuticals Earns $9M for Advancing ISIS-SMN Rx in Infants With Spinal Muscular Atrophy 4Isis Pharmaceuticals Earns $9M for Advancing ISIS-SMN Rx in Infants With Spinal Muscular Atrophy 5MeridianRx Earns Highest URAC Accreditation Status 2Pfenex To Report Fourth Quarter and Full Year 2014 Results and Provide Business Update 2
... KONG, Oct. 11 OrbusNeich today reported the completion ... its Genous Bio-engineered R stent at 11 sites in ... patient, controlled study is to demonstrate the safety and ... the Medtronic Endeavor® Sprint stent in patients with symptoms ...
... BioStorage Technologies, a global leader in sample management, ... pharmaceutical and biotechnology industries, has expanded its sample ... including sample aliquoting and nucleic acid extraction and ... sample management continues to grow, BioStorage Technologies has ...
Cached Medicine Technology:Randomized Clinical Trial of OrbusNeich's Genous™ Bio-engineered R stent™ in China Completes Patient Enrollment 2Industry Leader BioStorage Technologies Broadens Sample Management Operations to Include Laboratory Sample Preparation Services 2
(Date:3/6/2015)... 06, 2015 As healthcare providers ... and content from disparate systems, they are using ... and increase efficiency. Enterprise content management ... with core IT solutions, including electronic medical records ... IT applications. , The following organizations have ...
(Date:3/6/2015)... Saving Moses, a global humanitarian organization ... traveling to Angola, Africa March 7-14 to visit malnutrition ... , This will be the organizations fifth time to ... commitment to the region’s population by saving infants and ... with the mothers and babies of the malnutrition program, ...
(Date:3/6/2015)... Jose, California (PRWEB) March 06, 2015 ... also known as the pharmacokinetics of a drug refers ... a pharmaceutical compound inside an organism. When toxicity studies ... ADME-Tox or ADMET or ADME/Tox. Increasing focus on lowering ... adoption of ADME-toxicology testing worldwide. The traditional drug development ...
(Date:3/6/2015)... 06, 2015 “On Tap” takes the audience ... grand stage, to the silver screen and to modern day ... toe-tapping numbers and their famous eye-high kicks! Producers, directors and ... history of tap dancing in this robust show, showcasing one ... the United States. , “On Tap” is proud to ...
(Date:3/6/2015)... 06, 2015 At Natural Products ... today the launch of its powerful, location-aware iOS ... and sustainable products at any retailer that carries ... at Expo West Booth 6054. , Makeena’s ... Kosher, non-GMO, organic, Paleo, and vegan, among many ...
Breaking Medicine News(10 mins):Health News:Healthcare Providers Select OnBase by Hyland to Improve Patient Care and Streamline Administrative Departments 2Health News:Healthcare Providers Select OnBase by Hyland to Improve Patient Care and Streamline Administrative Departments 3Health News:Saving Moses Returns to Angola to Continue Giving Infants and Children a Chance to Live 2Health News:Growing Need to Reduce Drug Development Costs Drives the Global ADME-Toxicology Testing Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Growing Need to Reduce Drug Development Costs Drives the Global ADME-Toxicology Testing Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:The Legacy Dancers, a Dazzling Dance Troupe of Former Rockettes, Kick to New Heights in “On Tap: From Broadway to the Silver Screen” 2Health News:Makeena Launches App that Makes Healthy and Sustainable Products More Affordable for Shoppers 2Health News:Makeena Launches App that Makes Healthy and Sustainable Products More Affordable for Shoppers 3
... NEW BRUNSWICK, N.J. , March 15 ... female-specific AIDS service organization, has launched "I Stand With NJWAN", ... families, individuals, corporations, social service agencies, and the faith-based community ... women in NJ. At 35%, New Jersey has ...
... VEGAS , March 15 Each year, nearly three million ... drug addiction, prostitution, disease and mental illness.  In honor of National Safe ... Boxed In: Text-4-Help: 69866" campaign to raise awareness of the risks associated ... and across the country to youth in crisis.   , ...
... , March 15 /PRNewswire-FirstCall/ - The Westaim ... RiskMetrics Group (formerly Institutional Shareholder Services or "ISS") is ... the financing resolution to be submitted to shareholders of ... March 25, 2010 (the Financing Resolution). The ...
... 2010)Patient selection is key for vertebroplastya minimally invasive ... painful osteoporotic vertebral compression fractures that fail to ... successful, according to a study of more than ... Additionally, collaboration between an interventional radiologist and other ...
... Soulen, M.D., FSIR, delivered the 2010 Dr. Charles ... Radiology,s 35th Annual Scientific Meeting in Tampa, Fla. ... an interventional radiologist,s extraordinary contributions to the field, ... in interventional radiology. Soulen, who addressed "IR: ...
... around the heart, can provide extra information compared with standard ... research by cardiologists at Emory University School of Medicine. The ... be measured by X-ray imaging techniques such as CT or ... keeper, in that it could help a cardiologist decide whether ...
Cached Medicine News:Health News:For Women's History Month New Jersey Women and AIDS Network Launches 'I Stand With NJWAN' HIV Action and Awareness Campaign 2Health News:For Women's History Month New Jersey Women and AIDS Network Launches 'I Stand With NJWAN' HIV Action and Awareness Campaign 3Health News:National Safe Place Week Launches in Las Vegas to Help Prevent Teen Homelessness 2Health News:National Safe Place Week Launches in Las Vegas to Help Prevent Teen Homelessness 3Health News:National Safe Place Week Launches in Las Vegas to Help Prevent Teen Homelessness 4Health News:National Safe Place Week Launches in Las Vegas to Help Prevent Teen Homelessness 5Health News:National Safe Place Week Launches in Las Vegas to Help Prevent Teen Homelessness 6Health News:National Safe Place Week Launches in Las Vegas to Help Prevent Teen Homelessness 7Health News:National Safe Place Week Launches in Las Vegas to Help Prevent Teen Homelessness 8Health News:Westaim Announces Recommendation from RiskMetrics Group 2Health News:Westaim Announces Recommendation from RiskMetrics Group 3Health News:Westaim Announces Recommendation from RiskMetrics Group 4Health News:Westaim Announces Recommendation from RiskMetrics Group 5Health News:Vertebroplasty for patients with osteoporosis provides effective pain relief 2Health News:Vertebroplasty for patients with osteoporosis provides effective pain relief 3Health News:Society of Interventional Radiology Foundation honors Michael C. Soulen as Dotter lecturer 2Health News:Society of Interventional Radiology Foundation honors Michael C. Soulen as Dotter lecturer 3Health News:Society of Interventional Radiology Foundation honors Michael C. Soulen as Dotter lecturer 4Health News:Imaging fat layer around heart can help predict disease 2
Research Series 2100 Adjustable-volume Pipette, 20-200 l, single-channel with adjustable-volume setting...
Inquire...
... cover the range from 2ul to 5000ul. ... lock design prevents inadvertent volume change. Novel ... Whole pipette is autoclavable at 121C(250F). To ... Suitable for one-handed operation. Auto or ...
... viscosity and density. Proven ergonomic design reduces hand fatigue, prevents injury. Dry ... 100-1000 ... 1.0~1.5 Imprecision(%) ... 10 Dimensions: ...
Medicine Products: